EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Select your location
Local sites
Life Sciences
Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.
Aging populations and chronic disease are putting pressure on health resources around the world just as scientific progress, augmented intelligence and digital data are transforming the traditional health care models. This is causing a power shift with new entrants (often not driven by profit) disrupting the incumbents.
Staying competitive and providing the personalized experience that patients demand require life sciences organizations to find new ways of working. Partnering with others to share data, medicine and resources while anticipating trends and regulatory changes will help ensure sustainability in the increasingly evidence-based, outcomes-focused sector.
We help companies across the biotechnology, pharmaceutical and medical technology fields harness this disruption by forming the right alliances, better allocating resources and building trust with customers.
Our Latest thinking
Why licensing deals are a powerful source of growth in life sciences
Innovation is key in Life Sciences. In response to challenges, pharmaceutical companies increasingly turn to external innovation, leveraging licensing deals. Learn more.
03 Oct 2024
Dr. Markus von Minden
How implementation unlocks the true potential of AI in pharma
Discover why robust AI implementation is crucial for pharma innovation and how overcoming challenges leads to success.
18 Jul 2024
Patrick Grünewald
Life sciences dealmaking in a time of change
Life sciences companies are returning to dealmaking amid cost and revenue pressures – how will they find the right deals to secure value? Learn more.
08 Jan 2024
Subin Baral
How a Danish study unmasks psoriasis wait time
Danish study explores waiting and clinical management times based on real-world data. Read more
04 Dec 2023
Jens Olsen
Supply chain visibility strategic priority for pharma
With digitally driven end-to-end supply chain visibility, pharma companies will be better prepared for the next major supply chain disruption. Learn more.
04 Oct 2023
Derron Stark
How digital is changing the tax strategy for MedTech
As MedTech companies make substantial investments in digital technology, there are important tax implications that should be addressed. Learn more.
18 Aug 2023
Ana Maria Romero
How early diagnosis can transform health care
Mirxes’ Dr. Zhou Lihan shares his purpose and passion for a more proactive approach to medicine. Learn more.
14 Jun 2023
EY Global
Innovation can utilize data for value-based care
Organizations have the tools to deliver a better personalized health experience, but the ecosystem needs to collaborate to build this future. Learn more.
20 Mar 2023
Pamela Spence
Why life sciences tax departments need to act now on sustainability
Life sciences organizations should consider tax liabilities and compliance obligations resulting from myriad new sustainability taxes. Learn more.
11 Jan 2023
Rick Fonte
How do you build future supply chains to best serve patient needs?
In the wake of global disruptions, EY research aims to map out the future for supply chain transformation in the pharmaceutical industry. Read more.
18 Jul 2022
Derron Stark
How to navigate global transfer pricing controversy in life sciences
Life sciences companies face growing tax authority scrutiny of their transfer pricing practices and must prepare for escalating controversy.
07 Jun 2022
Rick Fonte
How you can create value in an intelligent health ecosystem
The intelligent health ecosystem will provide smarter insights and personalized health care experiences to patients, anytime and anywhere.
26 May 2022
Pamela Spence
How to navigate EU regulations for drug-device combination products
The new EU Medical Device Regulation (MDR) creates significant regulatory challenges for drug-device combination (DDC) product manufacturers.
10 Mar 2022
EY Global
How one entrepreneur seeks to make affordable health care a reality
Celltrion’s JungJin SEO shares his purpose and passion for more accessible health care. Learn more.
01 Mar 2022
EY Global
How ecosystem participation drives more value for life sciences deals
Biopharmas need to embrace strategic partnerships that share risk and reward to achieve their growth ambitions. Learn more.
10 Jan 2022
Subin Baral
How to account for outcome-based payment arrangements in life sciences
The use of outcome-based payment arrangements in the life sciences sector is growing in many jurisdictions, especially across Europe.
23 Sept 2021
EY Global
Five trends redefining the health sciences and wellness operating model
As demand from consumers accelerates the adoption of new technologies, we explore how companies can provide a more convenient health experience.
19 May 2021
Pamela Spence
How an ‘accidental entrepreneur’ is on a mission to change capitalism
Biocon’s Dr. Kiran Mazumdar-Shaw shares how she overcame challenges to turn a US$500 investment into one of Asia’s leading biotech companies.
19 Oct 2020
EY Global
How biopharmas can create long-term growth focusing on sustainability
In health care, there is a growing need to embed the perspectives of diverse stakeholders in the sustainability agenda.
16 Oct 2020
Pamela Spence
How life sciences companies reassess their supply chains due to COVID-19
The pandemic has shown the strengths and the weaknesses of life sciences supply chains. Now companies must adapt to build future resilience.
18 Sept 2020
EY Global
How EY can help
-
The EY Promotional Content Management Services team can provide you with support that will transform your processes and improve your results. Learn more.
Read more -
The EY Smart Reviewer can help your business accelerate and optimize the review and approval process for marketing and promotional materials. Find out how.
Read more -
Our Biopharma Launch Edge team can help your business achieve successful launches. Find out how.
Read more -
The EY Health Outcomes Platform aligns all stakeholders by providing a practical solution to operate value-based contracts at scale. Find out how.
Read more
Direct to your inbox
Stay up to date with our Editor's picks newsletter.